Optometrists in Sturgeon Bay, WI Accepting Medicare
9 Optometrists found. Showing 1 - 9
 Annika Paulsen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 165 N 3rd Ave, Sturgeon Bay, WI 54235 Phone: 920-743-2020 |
 Dr. John Eric Paulsen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 165 N 3rd Ave, Sturgeon Bay, WI 54235 Phone: 920-743-2020 Fax: 920-743-9601 |
 Door County Eye Associates, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 165 N 3rd Ave, Sturgeon Bay, WI 54235 Phone: 920-743-2020 |
Peninsula Vision Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1532 Michigan St, Sturgeon Bay, WI 54235 Phone: 920-743-5053 Fax: 920-743-8802 |
Baycare Clinic, Llp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 30 N 18th Ave, Sturgeon Bay, WI 54235 Phone: 920-743-9532 Fax: 920-743-9538 |
Dr. Michelle Marie Harper, O. D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1236 Green Bay Rd, Sturgeon Bay, WI 54235 Phone: 920-743-8884 Fax: 920-743-2519 |
Clear View Optical, S.c. Optometrist Medicare: Medicare Enrolled Practice Location: 1236 Green Bay Rd, Sturgeon Bay, WI 54235 Phone: 920-743-8884 Fax: 920-743-2519 |
Dr. Paul Andrew Filar, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1532 Michigan St, Sturgeon Bay, WI 54235 Phone: 920-743-5053 Fax: 920-743-8802 |
Mariah Leigh Metoxen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1532 Michigan St, Sturgeon Bay, WI 54235 Phone: 920-265-0780 |
News Archive
AAFP awards highest honor to North Carolina physician Karen L. Smith
The American Academy of Family Physicians today awarded its highest honor to Karen L. Smith, MD, FAAFP, of Raeford, North Carolina.
Emisphere, Novo Nordisk partner to develop and commercialize oral formulations of insulins
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
Zalicus advancing Z944 into further clinical development
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it is advancing Z944, its novel oral T-type calcium channel blocker, into further clinical development in the third quarter of 2013.
Bees pose biggest public health threat in Australia, research shows
An Australian-first national analysis of 13 years' data on bites and stings from venomous creatures reveals Australia's towns and cities are a hot-spot for encounters.
› Verified 6 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Optometrists
Speech-Language Pathologists
Podiatrists